InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
RYTM
Result 240 decisions over 120 months
Reset filters
Direction ?
Both240 Bought17 Sold223
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: RYTM
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
RYTM RHYTHM PHARMACEUTICALS, INC.
30 May 2019
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Sold, plan not stated
5,000
$126.55K
10.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
29 May 2019
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Sold, plan not stated
5,000
$127.55K
10.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
28 May 2019
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Sold, plan not stated
10,000
$253.80K
19.1%
RYTM RHYTHM PHARMACEUTICALS, INC.
18 Mar 2019
Gottesdiener Keith Michael
CEO & President
Sold, plan not stated
2,329
$70.50K
0.5%
RYTM RHYTHM PHARMACEUTICALS, INC.
15 Mar 2019
Gottesdiener Keith Michael
CEO & President
Sold, plan not stated
7,961
$239.15K
1.5%
RYTM RHYTHM PHARMACEUTICALS, INC.
14 Mar 2019
Gottesdiener Keith Michael
CEO & President
Sold, plan not stated
1,506
$45.26K
0.3%
RYTM RHYTHM PHARMACEUTICALS, INC.
13 Mar 2019
Gottesdiener Keith Michael
CEO & President
Sold, plan not stated
7,782
$233.93K
1.5%
RYTM RHYTHM PHARMACEUTICALS, INC.
27 Feb 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
1,814
$54.44K
0.3%
RYTM RHYTHM PHARMACEUTICALS, INC.
26 Feb 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
635
$19.13K
0.1%
RYTM RHYTHM PHARMACEUTICALS, INC.
19 Feb 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
918
$27.59K
0.2%
RYTM RHYTHM PHARMACEUTICALS, INC.
15 Feb 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
12,002
$360.30K
2.2%
RYTM RHYTHM PHARMACEUTICALS, INC.
13 Feb 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
3,934
$118.02K
0.7%
RYTM RHYTHM PHARMACEUTICALS, INC.
23 Jan 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
105
$3.17K
0.0%
RYTM RHYTHM PHARMACEUTICALS, INC.
22 Jan 2019
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
15,674
$471.00K
2.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
18 Jan 2019
Gottesdiener Keith Michael
CEO & President
Sold, plan not stated
10,115
$303.55K
1.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
16 Jan 2019
Gottesdiener Keith Michael
CEO & President
Sold, plan not stated
662
$19.86K
0.1%
RYTM RHYTHM PHARMACEUTICALS, INC.
16 Jan 2019
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Sold, plan not stated
200
$6.00K
0.5%
RYTM RHYTHM PHARMACEUTICALS, INC.
3 Dec 2018
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
563
$16.89K
0.1%
RYTM RHYTHM PHARMACEUTICALS, INC.
2 Nov 2018
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Sold, plan not stated
38,000
$1.14M
47.2%
RYTM RHYTHM PHARMACEUTICALS, INC.
2 Nov 2018
Gottesdiener Keith Michael
CEO and President
Sold, plan not stated
16,500
$496.32K
2.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
25 Sep 2018
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Sold, plan not stated 5×
31,800
$947.54K
37.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
22 May 2018
ORBIMED ADVISORS LLC
10% owner indirect
Sold, plan not stated 2×
19,580
$595.77K
0.7%
RYTM RHYTHM PHARMACEUTICALS, INC.
21 May 2018
ORBIMED ADVISORS LLC
10% owner indirect
Sold, plan not stated
62,500
$1.94M
2.2%
RYTM RHYTHM PHARMACEUTICALS, INC.
18 May 2018
ORBIMED ADVISORS LLC
10% owner indirect
Sold, plan not stated
69,136
$2.13M
2.4%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
Viswanathan Ravi
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
SANDELL SCOTT D
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
MOTT DAVID M
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
KERINS PATRICK J
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
BASKETT FOREST
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
BARRIS PETER J
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
BARRETT M JAMES
10% owner indirect
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
NEW ENTERPRISE ASSOCIATES 13 LP
10% owner
Bought
550,000
$9.35M
12.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
ORBIMED ADVISORS LLC
10% owner indirect
Bought
355,000
$6.04M
13.9%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
Flynn James E
10% owner indirect
Bought 2×
355,000
$6.04M
313%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
MPM BIOVENTURES V, L.P.
10% owner indirect
Bought
100,000
$1.70M
3.9%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
Foley Todd
Director indirect
Bought
100,000
$1.70M
3.9%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
PFIZER INC
10% owner
Bought
40,000
$680.00K
2.9%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
Meeker David P
Director
Bought
25,000
$425.00K
32.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
Ipsen, S.A.
10% owner indirect
Bought
20,000
$340.00K
2.5%
RYTM RHYTHM PHARMACEUTICALS, INC.
5 Oct 2017
BAKER BROS. ADVISORS LP
Former 10% owner indirect
Bought 2×
885,000
$15.05M
89.1%
Showing 201–240 of 240. ← Newer Page 5 of 5